NCT04715191
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
Clinical trial condition
Yolk Sac Tumor
Explore clinical trials studying Yolk Sac Tumor. Study availability and eligibility vary by location and protocol.
11 public trials
5 recruiting studies
Yolk Sac Tumor trial results
Recruiting
Agnostic Therapy in Rare Solid Tumors
NCT06638931
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
- Locations
-
- Hospital São Carlos Fortaleza, Ceará, Brazil
- Hospital São Rafael Salvador, Estado de Bahia, Brazil
- Hospital Santa Cruz Curitiba, Paraná, Brazil
- IDOR Recife Recife, Pernambuco, Brazil
NCT07148050
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +40 more
- Locations
-
- Seattle Children's Hospital Seattle, Washington, United States
NCT06198296
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
NCT05564026
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Embryonal, +20 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
Not yet recruiting
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
NCT07224568
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +22 more
- Locations
-
- Fred Hutch Cancer Center Seattle, Washington, United States
Active, not recruiting
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT02375204
- Conditions
- Adenocarcinoma, Carcinoma, Childhood Teratoma, +22 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, not recruiting
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors
NCT05103631
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
Active, not recruiting
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
NCT04377932
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
Completed
Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children
NCT06341998
- Conditions
- Endodermal Sinus Tumor, Germ Cell Tumor, Mesonephroma, +4 more
- Locations
-
- Shandong Cancer Hospital and Institute Jinan, Shandong, China